Trump’s new executive orders may hit Indian Pharma exports, reshape global drug supply chains: Report
The recent executive orders on pharma issued by President Donald Trump are expected to create significant challenges for Indian pharmaceutical companies, especially those operating in the U.S. generic drug market,…
Indian Pharma Poised To Gain As US Tariffs Impact Global Rivals: JP Morgan Report
Mumbai: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report. Essentially, Indian pharmaceutical companies have the potential…
Indian pharma companies set to see 9-11% growth in FY25, says Icra
Indian pharmaceutical companies are set to experience 9-11 per cent revenue growth in FY25, driven by strong performances in key markets such as the United States, Europe, and emerging regions,…
Pharmaceutical companies prepare to comply with ethical marketing code
Pharmaceutical (pharma) bodies have welcomed the government’s move to request chief executive officers (CEOs) of all pharma companies submit, by June 30, an undertaking citing compliance with the newly notified…
